Contract 75D30122D13472
Merck Sharp & Dohme Llc · Department Of Health And Human Services · March 19, 2026
Merck Sharp & Dohme Llc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on March 19, 2026 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $3.30 billion.
Contract details
- PIID
- 75D30122D13472
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 19, 2026
Description
VACCINES FOR CHILDREN
Modification timeline
-
March 19, 2026Mod P00011 · Other Administrative Action$2.17B
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Seqirus USA Inc | Department Of Health And Human Services | March 27, 2026 | $2.02M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30122D13472?
Contract 75D30122D13472 is a federal contract awarded to Merck Sharp & Dohme Llc by Department Of Health And Human Services on March 19, 2026 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75D30122D13472?
Merck Sharp & Dohme Llc won contract 75D30122D13472 from Department Of Health And Human Services.
How much is contract 75D30122D13472 worth?
Contract 75D30122D13472 has obligated $0 to date but carries a potential ceiling of $3.30 billion if fully funded and all options are exercised.